{"entity":{"type":"insider","cik":"0001612842","url":"/insider/0001612842","json_url":"/insider/0001612842.json","name":"Wagner Paul A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":8,"first":"2020-06-29","last":"2023-12-20","span_basis":"filed_date"},"name_variants":[{"name":"Wagner Paul A.","source":"filing","n_filings":8,"first_seen":"2020-06-29","last_seen":"2023-12-20"}],"transactions":[{"id":8705303,"accession":"0001209191-23-059297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059297","line_url":"/filing/0001209191-23-059297#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.7525,"price_display":"0.75","price_state":"stated","total_value":7525.0,"total_display":"7,525.00","total_whole":"7,525","shares_owned_after":1823236.0,"shares_owned_after_display":"1,823,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8406429,"accession":"0001209191-23-058867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058867","line_url":"/filing/0001209191-23-058867#line-2","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":7200.0,"total_display":"7,200.00","total_whole":"7,200","shares_owned_after":1813236.0,"shares_owned_after_display":"1,813,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-15","scope":"insider"},{"id":8406425,"accession":"0001209191-23-058867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058867","line_url":"/filing/0001209191-23-058867#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10520.0,"shares_display":"10,520","price_per_share":0.6988,"price_display":"0.70","price_state":"stated","total_value":7351.376,"total_display":"7,351.38","total_whole":"7,351","shares_owned_after":1803236.0,"shares_owned_after_display":"1,803,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":8223570,"accession":"0001209191-23-058404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058404","line_url":"/filing/0001209191-23-058404#line-2","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4776.0,"shares_display":"4,776","price_per_share":0.6466,"price_display":"0.65","price_state":"stated","total_value":3088.1616,"total_display":"3,088.16","total_whole":"3,088","shares_owned_after":1792716.0,"shares_owned_after_display":"1,792,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-12","scope":"insider"},{"id":8223564,"accession":"0001209191-23-058404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058404","line_url":"/filing/0001209191-23-058404#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.6475,"price_display":"0.65","price_state":"stated","total_value":16187.5,"total_display":"16,187.50","total_whole":"16,188","shares_owned_after":1787940.0,"shares_owned_after_display":"1,787,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8255771,"accession":"0001209191-23-057989","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057989","line_url":"/filing/0001209191-23-057989#line-2","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":9300.0,"total_display":"9,300.00","total_whole":"9,300","shares_owned_after":1762940.0,"shares_owned_after_display":"1,762,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-08","scope":"insider"},{"id":8255767,"accession":"0001209191-23-057989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057989","line_url":"/filing/0001209191-23-057989#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36203.0,"shares_display":"36,203","price_per_share":0.5847,"price_display":"0.58","price_state":"stated","total_value":21167.8941,"total_display":"21,167.89","total_whole":"21,168","shares_owned_after":1747940.0,"shares_owned_after_display":"1,747,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-08","scope":"insider"},{"id":8335695,"accession":"0001209191-23-056522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-056522","line_url":"/filing/0001209191-23-056522#line-4","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":172.0,"total_display":"172.00","total_whole":"172","shares_owned_after":1711737.0,"shares_owned_after_display":"1,711,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-22","scope":"insider"},{"id":8335691,"accession":"0001209191-23-056522","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-056522","line_url":"/filing/0001209191-23-056522","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6966.0,"shares_display":"6,966","price_per_share":0.43753804191788687,"price_display":"0.44","price_state":"stated","total_value":3047.89,"total_display":"3,047.89","total_whole":"3,048","shares_owned_after":1709671.0,"shares_owned_after_display":"1,709,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider","n_lines":3},{"id":6827045,"accession":"0001209191-22-061903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-061903","line_url":"/filing/0001209191-22-061903#line-2","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44024.0,"shares_display":"44,024","price_per_share":1.0676,"price_display":"1.07","price_state":"stated","total_value":47000.0224,"total_display":"47,000.02","total_whole":"47,000","shares_owned_after":1379049.0,"shares_owned_after_display":"1,379,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":6827041,"accession":"0001209191-22-061903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-061903","line_url":"/filing/0001209191-22-061903#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55976.0,"shares_display":"55,976","price_per_share":1.0303,"price_display":"1.03","price_state":"stated","total_value":57672.0728,"total_display":"57,672.07","total_whole":"57,672","shares_owned_after":1335025.0,"shares_owned_after_display":"1,335,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":5455599,"accession":"0000899243-21-035344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-035344","line_url":"/filing/0000899243-21-035344#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":4.3471,"price_display":"4.35","price_state":"stated","total_value":4347100.0,"total_display":"4,347,100.00","total_whole":"4,347,100","shares_owned_after":1279049.0,"shares_owned_after_display":"1,279,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-08","scope":"insider"},{"id":2783353,"accession":"0001209191-20-039272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-039272","line_url":"/filing/0001209191-20-039272#line-1","is_derivative":false,"issuer_cik":"0001419041","issuer_name":"Forte Biosciences, Inc.","issuer_ticker":"FBRX","issuer_name_source":null,"issuer_url":"/issuer/0001419041","owner_cik":"0001612842","owner_name":"Wagner Paul A.","owner_display_name":"Wagner Paul A.","owner_url":"/insider/0001612842","role":"Director, Officer, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":14.4794,"price_display":"14.48","price_state":"stated","total_value":101355.8,"total_display":"101,355.80","total_whole":"101,356","shares_owned_after":2279049.0,"shares_owned_after_display":"2,279,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-25","filed_date":"2020-06-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419041","name":"Forte Biosciences, Inc.","url":"/issuer/0001419041","role":"Director, Officer, Ten percent owner","n_filings":8,"first_seen":"2020-06-29","last_seen":"2023-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612842","retrieved_at":"2026-08-27T06:15:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}